Health
Atomically Accurate De Novo Design Of Antibodies With Rfdiffusion
By Nature
Antibodies are the dominant class of protein therapeutics, with over 160 antibody therapeutics currently licensed globally and a market value expected to reach US$445 billion in the next 5 years4. Antibody development generally proceeds in two stages ...Read more
